| 1. |
- Grechnev, G. E., et al.
(författare)
-
Anisotropy of magnetic properties of Fe1+y Te
- 2014
-
Ingår i: Journal of Physics. - : IOP Publishing. - 0953-8984 .- 1361-648X. ; 26:43, s. 436003-
-
Tidskriftsartikel (refereegranskat)abstract
- The magnetic properties of Fe1+y Te single crystals (y similar or equal to 0.1 divided by 0.18) were studied at temperatures 4.2 divided by 300 K. At an ambient pressure, with decreasing temperature a drastic drop in chi(T) was confirmed at T similar or equal to 60 divided by 65 K, which appears to be closely related to the antiferromagnetic (AFM) ordering. It is found that the magnitudes of the anisotropy of magnetic susceptibility Delta chi. in the AFM phase are close in the studied samples, whereas the sign of the anisotropy apparently depends on the small variations of the excess iron y in Fe1+y Te samples. The performed DFT calculations of the electronic structure and magnetic properties for the stoichiometric FeTe compound indicate the presence of frustrated AFM ground states. There are very close energies and magnetic moments for the double stripe configurations, with the AFM axes oriented either on the basal plane or along the [0 0 1] direction. Presumably, both these configurations can be realized in Fe1+y Te single crystals, depending on the variations of the excess iron. This can provide different signs of magnetic anisotropy in the AFM phase, presently observed in the Fe1+y Te samples. For these types of AFM configuration, the calculations for the FeTe values of Delta chi are consistent with our experimental data.
|
|
| 2. |
|
|
| 3. |
- Kovalchuk, T, et al.
(författare)
-
Case Reports: Emery-Dreifuss Muscular Dystrophy Presenting as a Heart Rhythm Disorders in Children
- 2021
-
Ingår i: Frontiers in cardiovascular medicine. - : Frontiers Media SA. - 2297-055X. ; 8, s. 668231-
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Emery-Dreifuss muscular dystrophy (EDMD) is inherited muscle dystrophy often accompanied by cardiac abnormalities in the form of supraventricular arrhythmias, conduction defects and sinus node dysfunction. Cardiac phenotype typically arises years after skeletal muscle presentation, though, could be severe and life-threatening. The defined clinical manifestation with joint contractures, progressive muscle weakness and atrophy, as well as cardiac symptoms are observed by the third decade of life. Still, clinical course and sequence of muscle and cardiac signs may be variable and depends on the genotype. Cardiac abnormalities in patients with EDMD in pediatric age are not commonly seen. Here we describe five patients with different forms of EDMD (X-linked and autosomal-dominant) caused by the mutations in EMD and LMNA genes, presented with early onset of cardiac abnormalities and no prominent skeletal muscle phenotype. The predominant forms of cardiac pathology were atrial arrhythmias and conduction disturbances that progress over time. The presented cases discussed in the light of therapeutic strategy, including radiofrequency ablation and antiarrhythmic devices implantation, and the importance of thorough neurological and genetic screening in pediatric patients presenting with complex heart rhythm disorders.
|
|
| 4. |
- Mitrofanova, A, et al.
(författare)
-
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
- 2019
-
Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 10:1, s. 2692-
-
Tidskriftsartikel (refereegranskat)abstract
- Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3b) is a lipid raft enzyme that regulates plasma membrane (PM) fluidity. Here we report that SMPDL3b excess, as observed in podocytes in diabetic kidney disease (DKD), impairs insulin receptor isoform B-dependent pro-survival insulin signaling by interfering with insulin receptor isoforms binding to caveolin-1 in the PM. SMPDL3b excess affects the production of active sphingolipids resulting in decreased ceramide-1-phosphate (C1P) content as observed in human podocytes in vitro and in kidney cortexes of diabetic db/db mice in vivo. Podocyte-specific Smpdl3b deficiency in db/db mice is sufficient to restore kidney cortex C1P content and to protect from DKD. Exogenous administration of C1P restores IR signaling in vitro and prevents established DKD progression in vivo. Taken together, we identify SMPDL3b as a modulator of insulin signaling and demonstrate that supplementation with exogenous C1P may represent a lipid therapeutic strategy to treat diabetic complications such as DKD.
|
|
| 5. |
- Rodina, T.A., et al.
(författare)
-
Synthesis, structure, and 13C and 31P CP/MAS NMR of crystalline modifications of the polynuclear thallium(I) O,O′-dicyclohexyl phosphorodithioate complex [Tl{S2P(O-cyclo-C6H11)2}]n
- 2009
-
Ingår i: Russian Journal of Inorganic Chemistry. - 0036-0236 .- 1531-8613. ; 54:11, s. 1779-1788
-
Tidskriftsartikel (refereegranskat)abstract
- Two crystalline modifications (Ia and Ib) of the polynuclear thallium (I) O,O′-dicyclohexyl phosphorodithioate complex [Tl{S2P(O-cyclo-C6H11)2}] n have been synthesized and characterized by CP/MAS NMR (13C, 31P). From full 31P CP/MAS NMR spectra, the χ2 plots were constructed to calculate the 31P chemical shift anisotropy 31P - δaniso = (δzz - δiso) and asymmetry parameters η = (δ yy - δ xx )/(δ zz - δiso). The data obtained for the O,O′-dicyclohexyl phosphorodithioate (Dtph) groups (in both modifications) are evidence that the 31P chemical shift tensors are intermediate between rhombic and axially symmetric. However, whereas the rhombic component dominates for Ia, the tensor for Ib is close to axially symmetric (for δ zz < δ yy ≈ δ xx ). The same pattern of the MAS spectra corresponding to negative δaniso (δ zz < δ yy < δ xx ) points to a bridging or terminal/bridging coordination mode of the Dtph groups. X-ray crystallography shows that complex Ib has a polynuclear structure (of the chain polymer type). The chains are composed of alternating structurally nonequivalent noncentrosymmetric binuclear molecules [Tl2{S2P(O-cyclo-C6H11)2}2]. All Dtph ligands have the terminal/μ3-bridging coordination mode.
|
|
| 6. |
- Vakhrushev, Y, et al.
(författare)
-
RBM20-Associated Ventricular Arrhythmias in a Patient with Structurally Normal Heart
- 2021
-
Ingår i: Genes. - : MDPI AG. - 2073-4425. ; 12:1
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- RBM20 (RNA-binding motif protein 20) is a splicing factor targeting multiple cardiac genes, and its mutations cause cardiomyopathies. Originally, RBM20 mutations were discovered to cause the development of dilated cardiomyopathy by erroneous splicing of the gene TTN (titin). Titin is a giant protein found in a structure of the sarcomere that functions as a molecular spring and provides a passive stiffness to the cardiomyocyte. Later, RBM20 mutations were also described in association with arrhythmogenic right ventricular cardiomyopathy and left ventricular noncompaction cardiomyopathy. Here, we present a clinical case of a rare arrhythmogenic phenotype and no structural cardiac abnormalities associated with a RBM20 genetic variant of uncertain significance.
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
|
|
